393 related articles for article (PubMed ID: 2122463)
21. Molecular analysis in patients with mucopolysaccharidosis type II suggests that DXS466 maps within the Hunter gene.
Steglich C; Bunge S; Hulsebos T; Beck M; Brandt NJ; Schwinger E; Hopwood JJ; Gal A
Hum Genet; 1993 Sep; 92(2):179-82. PubMed ID: 8103756
[TBL] [Abstract][Full Text] [Related]
22. Analysis of a 43.6 kb deletion in a patient with Hunter syndrome (MPSII): identification of a fusion transcript including sequences from the gene W and the IDS gene.
Lagerstedt K; Carlberg BM; Karimi-Nejad R; Kleijer WJ; Bondeson ML
Hum Mutat; 2000; 15(4):324-31. PubMed ID: 10737977
[TBL] [Abstract][Full Text] [Related]
23. Presence of an IDS-related locus (IDS2) in Xq28 complicates the mutational analysis of Hunter syndrome.
Bondeson ML; Malmgren H; Dahl N; Carlberg BM; Pettersson U
Eur J Hum Genet; 1995; 3(4):219-27. PubMed ID: 8528670
[TBL] [Abstract][Full Text] [Related]
24. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
Christianto A; Watanabe H; Nakajima T; Inazu T
Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
[TBL] [Abstract][Full Text] [Related]
25. Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28.
Rathmann M; Bunge S; Steglich C; Schwinger E; Gal A
Hum Genet; 1995 Jan; 95(1):34-8. PubMed ID: 7814022
[TBL] [Abstract][Full Text] [Related]
26. A 38.8 kb deletion mutation of the iduronate-2-sulfatase gene in a patient with Hunter syndrome.
Chou YY; Chao SC; Kuo PL; Lin SJ
J Formos Med Assoc; 2005 Apr; 104(4):273-5. PubMed ID: 15909065
[TBL] [Abstract][Full Text] [Related]
27. Detection of point mutations and a gross deletion in six Hunter syndrome patients.
Flomen RH; Green PM; Bentley DR; Giannelli F; Green EP
Genomics; 1992 Jul; 13(3):543-50. PubMed ID: 1639384
[TBL] [Abstract][Full Text] [Related]
28. Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl.
Semyachkina AN; Voskoboeva EY; Zakharova EY; Nikolaeva EA; Kanivets IV; Kolotii AD; Baydakova GV; Kharabadze MN; Kuramagomedova RG; Melnikova NV
BMC Med Genet; 2019 May; 20(1):66. PubMed ID: 31046699
[TBL] [Abstract][Full Text] [Related]
29. Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene.
Flomen RH; Green EP; Green PM; Bentley DR; Giannelli F
Hum Mol Genet; 1993 Jan; 2(1):5-10. PubMed ID: 8490623
[TBL] [Abstract][Full Text] [Related]
30. Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II).
Crotty PL; Whitley CB
Hum Genet; 1992 Nov; 90(3):285-8. PubMed ID: 1283150
[TBL] [Abstract][Full Text] [Related]
31. Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II).
Schröder W; Wulff K; Wehnert M; Seidlitz G; Herrmann FH
Hum Mutat; 1994; 4(2):128-31. PubMed ID: 7981716
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).
Li P; Bellows AB; Thompson JN
J Med Genet; 1999 Jan; 36(1):21-7. PubMed ID: 9950361
[TBL] [Abstract][Full Text] [Related]
33. Human glucosamine-6-sulfatase cDNA reveals homology with steroid sulfatase.
Robertson DA; Freeman C; Nelson PV; Morris CP; Hopwood JJ
Biochem Biophys Res Commun; 1988 Nov; 157(1):218-24. PubMed ID: 3196333
[TBL] [Abstract][Full Text] [Related]
34. Molecular and phenotypic variation in patients with severe Hunter syndrome.
Timms KM; Bondeson ML; Ansari-Lari MA; Lagerstedt K; Muzny DM; Dugan-Rocha SP; Nelson DL; Pettersson U; Gibbs RA
Hum Mol Genet; 1997 Mar; 6(3):479-86. PubMed ID: 9147653
[TBL] [Abstract][Full Text] [Related]
35. Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations.
Kim CH; Hwang HZ; Song SM; Paik KH; Kwon EK; Moon KB; Yoon JH; Han CK; Jin DK
Hum Mutat; 2003 Apr; 21(4):449-50. PubMed ID: 12655569
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of DNA and RNA in Hunter patients.
Annella T; Daniele A; Di Natale P
Hum Genet; 1993 Oct; 92(4):350-2. PubMed ID: 7693576
[TBL] [Abstract][Full Text] [Related]
37. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
[TBL] [Abstract][Full Text] [Related]
38. The effect of four mutations on the expression of iduronate-2-sulfatase in mucopolysaccharidosis type II.
Bonuccelli G; Di Natale P; Corsolini F; Villani G; Regis S; Filocamo M
Biochim Biophys Acta; 2001 Nov; 1537(3):233-8. PubMed ID: 11731225
[TBL] [Abstract][Full Text] [Related]
39. Mutational spectrum of the iduronate-2-sulfatase (IDS) gene in 36 unrelated Russian MPS II patients.
Karsten S; Voskoboeva E; Tishkanina S; Pettersson U; Krasnopolskaja X; Bondeson ML
Hum Genet; 1998 Dec; 103(6):732-5. PubMed ID: 9921913
[TBL] [Abstract][Full Text] [Related]
40. [A new mutation of iduronate-2-sulfatase gene from the patient with Hunter syndrome].
Guo YB; Lin QD; Du CS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):67-9. PubMed ID: 16456790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
